NCT06093672 Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera Status RECRUITING Phase PHASE3
NCT06063486 Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms Status RECRUITING Phase PHASE2
NCT06033586 Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05993065 Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution Width in Polycythemia Vera and Secondary Erythrocytosis. Status UNKNOWN Phase N/A
NCT05870475 Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV Status RECRUITING Phase PHASE2
NCT05853458 Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors Status TERMINATED Phase PHASE4
NCT05853445 A Prospective, Non-interventional Study of JAKAVI® (Ruxolitinib) Treatment in Patients With Polycythemia Vera Status COMPLETED Phase N/A
NCT05566535 Changes in QoL and Symptoms in Patients With Polycythemia Vera Receiving Ruxo in a Routine Clinical Practice Status UNKNOWN Phase N/A
NCT05558696 A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004) Status COMPLETED Phase PHASE2
NCT05548062 Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05499013 Study to Assess SLN124 in Patients With Polycythemia Vera Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05485948 A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05481151 A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05269771 MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera Status NO_LONGER_AVAILABLE Phase N/A
NCT05210790 A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05198960 AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms Status RECRUITING Phase PHASE3
NCT05123365 An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms Status RECRUITING Phase PHASE1/PHASE2